Nevro Corp. 1N7.F Stock
Nevro Corp. Price Chart
Nevro Corp. 1N7.F Financial and Trading Overview
| Nevro Corp. stock price | 12.2 EUR |
| Previous Close | 22.4 EUR |
| Open | 22.6 EUR |
| Bid | 22.6 EUR x 100000 |
| Ask | 23 EUR x 100000 |
| Day's Range | 22.6 - 22.6 EUR |
| 52 Week Range | 21.4 - 52 EUR |
| Volume | 80 EUR |
| Avg. Volume | 6 EUR |
| Market Cap | 824.93M EUR |
| Beta (5Y Monthly) | 0.871478 |
| PE Ratio (TTM) | 322.85715 |
| EPS (TTM) | -2.39 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 139.62 EUR |
1N7.F Valuation Measures
| Enterprise Value | 647.65M EUR |
| Trailing P/E | 322.85715 |
| Forward P/E | -12.216216 |
| PEG Ratio (5 yr expected) | -1.79 |
| Price/Sales (ttm) | 1.988506 |
| Price/Book (mrq) | 2.6780424 |
| Enterprise Value/Revenue | 1.561 |
| Enterprise Value/EBITDA | -6.735 |
Trading Information
Nevro Corp. Stock Price History
| Beta (5Y Monthly) | 0.871478 |
| 52-Week Change | -43.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 52 EUR |
| 52 Week Low | 21.4 EUR |
| 50-Day Moving Average | 27.65 EUR |
| 200-Day Moving Average | 35.88 EUR |
1N7.F Share Statistics
| Avg. Volume (3 month) | 6 EUR |
| Avg. Daily Volume (10-Days) | 8 EUR |
| Shares Outstanding | 35.82M |
| Float | 34.94M |
| Short Ratio | N/A |
| % Held by Insiders | 2.24% |
| % Held by Institutions | 111.88% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0.55% |
| Operating Margin (ttm) | -24.68% |
| Gross Margin | 67.95% |
| EBITDA Margin | -23.17% |
Management Effectiveness
| Return on Assets (ttm) | -11.55% |
| Return on Equity (ttm) | 0.84% |
Income Statement
| Revenue (ttm) | 414.85M EUR |
| Revenue Per Share (ttm) | 11.7 EUR |
| Quarterly Revenue Growth (yoy) | 9.70% |
| Gross Profit (ttm) | 276.37M EUR |
| EBITDA | -96164000 EUR |
| Net Income Avi to Common (ttm) | 2.3M EUR |
| Diluted EPS (ttm) | 0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 341.77M EUR |
| Total Cash Per Share (mrq) | 9.54 EUR |
| Total Debt (mrq) | 201.44M EUR |
| Total Debt/Equity (mrq) | 66.87 EUR |
| Current Ratio (mrq) | 7.147 |
| Book Value Per Share (mrq) | 8.439 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 23.78M EUR |
| Levered Free Cash Flow (ttm) | -30835000 EUR |
Profile of Nevro Corp.
| Country | Germany |
| State | CA |
| City | Redwood City |
| Address | 1800 Bridge Parkway |
| ZIP | 94065 |
| Phone | 650 251 0005 |
| Website | https://nevro.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 1087 |
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Q&A For Nevro Corp. Stock
What is a current 1N7.F stock price?
Nevro Corp. 1N7.F stock price today per share is 12.2 EUR.
How to purchase Nevro Corp. stock?
You can buy 1N7.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nevro Corp.?
The stock symbol or ticker of Nevro Corp. is 1N7.F.
Which industry does the Nevro Corp. company belong to?
The Nevro Corp. industry is Medical Devices.
How many shares does Nevro Corp. have in circulation?
The max supply of Nevro Corp. shares is 36.8M.
What is Nevro Corp. Price to Earnings Ratio (PE Ratio)?
Nevro Corp. PE Ratio is now.
What was Nevro Corp. earnings per share over the trailing 12 months (TTM)?
Nevro Corp. EPS is -2.39 EUR over the trailing 12 months.
Which sector does the Nevro Corp. company belong to?
The Nevro Corp. sector is Healthcare.